Mytigate

Claimed Profile, managed by the company

Claim Company

Eschborn

Germany

http://www.mytigate.com

Mytigate is a state-of-the-art, fully digital platform that ensures that pharmaceutical manufacturers comply with the Guidelines on Good Distribution Practice by · Providing a digital lane risk assessment, · Continuous monitoring of lane quality and · Presenting the proper documentation for regulatory authorities.

Active

Transportation

Status

Active

City (Headquarter)

Eschborn

Country

Germany

FTE’s

Employees

Founding Date

7/12/2017

Funding ($)

600000

Phone

+49 (0) 172-2693329

Contact Email

Yvonne.Ziegler@mytigate.com

Founder

Founders

Prof. Dr. Yvonne Ziegler

Artem Andrianov

Status

Active

City (Headquarter)

Eschborn

Country

Germany

FTE’s

xxx

Employees

Funding ($)

xxxxxxx

Phone

xxxxxxxx

Founder

Founders

xxxxx

xxxxxx

xxxxx

For more details on this startup, you must register for a startup base account

Status

Active

City (Headquarter)

Eschborn

Country

Germany

FTE’s

xxx

Employees

Funding ($)

xxxxxxx

Phone

xxxxxxxx

Founder

Founders

xxxxx

xxxxxx

xxxxx

For more details on this startup,

you must upgrade your account.

Upgrade

Techsegment

Software

Machine Learning

IoT

Big Data

Market Sub-Segment

Planning

Supply Chain Visibility

Transportation

Last Mile Delivery

Warehousing

Supplier Management

Sustainability Sub-Segment

No items found.

For more details on this startup, you must register for a startup base account

Techsegment

xxxxxx

Sustainability Sub-Segment

xxxxxx

Market Sub-Segment

xxxxxx

For more details on this startup,

you must upgrade your account.

Upgrade

Techsegment

xxxxxx

Sustainability Sub-Segment

xxxxxx

Market Sub-Segment

xxxxxx

Description

Company USP

– GDP Compliance: Comply to GDP regulations and document your risk-based transport selections for regulators – Scientific Risk Assessment: Digitally verify transport lanes through a scientific risk assessment – End-to-End Visibility: Ensure end-to-end visibility on lanes, and supply chain partners' capabilities and infrastructure – Less Incidents: Minimise the number of incidents and deviations – Savings: Save costs on investigative CAPAs, scraping cases, insurance claims, and packaging – Validated Tool: Mytigate is validated tool according to FDA Guidelines CFR21 Part 11 – Open Application Programing: Interface (API) system Interoperability with other in-house systems through an Open API system

Problems Solved

Since the introduction of the EU GDP Guidelines in 2013, pharma companies and their forwarders are required to assure quality throughout their supply chain and to conduct a risk-based selection process for their transport partners. Until now, however, many have been unable to meet these requirements. Mytigate – being an innovative, web-based service – offers a new solution that will help you to be compliant, and to select lanes using those supply chain partners that offer the highest quality and lowest risk. Risks are continuously calculated, starting from the design phase of the lane through to the operating phase. The calculation of these risks is based on state-of-the-art, scientific-mathematical risk modelling using information from transport partners (self-assessment of capabilities, and certificates), weather database providers, and pharma companies (operational deviations, root cause data, and temperature logger data). By these means, Mytigate aims to be a must-have risk management standard within the pharma industry and to be the driver for innovation in the transport and supply chain industries. Through analysis of this data, predictive analytics can be applied to identify the trends.

For more details on this startup, you must register for a startup base account

Description

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Company USP

For more details on this startup,

you must upgrade your account.

Upgrade

Description

Company USP

Business Model

B2B Software

Target Customers

Pharmaceutical companies and their forwarders

Reference Customers

Test customers: Sanofi, Bayer AG, Boehringer Ingelheim

Operating Geographies

Germany

For more details on this startup, you must register for a startup base account

Business Model

xxxxxx

Target Customers

xxxxxx

Reference Customers

xxxxxx

Operating Geographies

xxxxxx

For more details on this startup,

you must upgrade your account.

Upgrade

Business Model

xxxxxx

Target Customers

xxxxxx

Reference Customers

xxxxxx

Operating Geographies

xxxxxx

Attachments

a10473_MYTIGATE-Pharma-Brochure.pdf

For more details on this startup, you must register for a startup base account

Attachments

lorem-ipsum.pdf

For more details on this startup,

you must upgrade your account.

Upgrade

Attachments

lorem-ipsum.pdf

Upgrade your Account for more features

For a free upgrade, you get access to the entire startups’ profiles

Company’s funding & founders

Segmentation & Solution Details

Target Customers & Traction

Upgrade

Register with us for free

With

Segments

Up to

552

Companies in the Database

From

European Countries

Mytigate

Upgrade your Account for more features

Register with us for free

We Empower

Sustainable Supply Chains